MTDH and metastatic malignant neoplasm: One potential explanation of this discrepancy could be that increase AEG-1 was observed in the nucleus of GBC patients, unlike other metastatic cancers where it is detected in the cytoplasm and cell membrane further stressing that the mechanism that drives AEG-1 localization requires in-depth scrutiny.